These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21451411)

  • 1. Management of autoimmune hepatitis.
    Mayo MJ
    Curr Opin Gastroenterol; 2011 May; 27(3):224-30. PubMed ID: 21451411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of immunosuppression in autoimmune hepatitis: A current literature review.
    Cropley A; Weltman M
    Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.
    De Lemos-Bonotto M; Valle-Tovo C; Costabeber AM; Mattos AA; Azeredo-da-Silva ALF
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):212-216. PubMed ID: 29227329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
    Fallatah HI; Akbar HO
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert clinical management of autoimmune hepatitis in the real world.
    Liberal R; de Boer YS; Andrade RJ; Bouma G; Dalekos GN; Floreani A; Gleeson D; Hirschfield GM; Invernizzi P; Lenzi M; Lohse AW; Macedo G; Milkiewicz P; Terziroli B; van Hoek B; Vierling JM; Heneghan MA;
    Aliment Pharmacol Ther; 2017 Mar; 45(5):723-732. PubMed ID: 28004405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
    Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
    J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hepatitis: Current and future therapeutic options.
    Doycheva I; Watt KD; Gulamhusein AF
    Liver Int; 2019 Jun; 39(6):1002-1013. PubMed ID: 30716203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
    Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
    Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
    Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
    J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for autoimmune hepatitis.
    Manns MP; Strassburg CP
    Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the diagnosis and management of autoimmune hepatitis.
    Dalekos GN; Samakidou A; Lyberopoulou A; Banakou E; Gatselis NK
    Pol Arch Intern Med; 2022 Sep; 132(9):. PubMed ID: 36093593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune hepatitis: recent update on diagnosis and treatment].
    Lee YS
    Korean J Hepatol; 2006 Sep; 12(3):318-32. PubMed ID: 16998286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.
    Stoelinga AEC; Tushuizen ME; van den Hout WB; Girondo MDMR; de Vries ES; Levens AD; Moes DAR; Gevers TJG; van der Meer S; Brouwer HT; de Jonge HJM; de Boer YS; Beuers UHW; van der Meer AJ; van den Berg AP; Guichelaar MMJ; Drenth JPH; van Hoek B;
    Trials; 2024 Jan; 25(1):61. PubMed ID: 38233878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge issues in autoimmune hepatitis.
    Liberal R; Krawitt EL; Vierling JM; Manns MP; Mieli-Vergani G; Vergani D
    J Autoimmun; 2016 Dec; 75():6-19. PubMed ID: 27502148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies in autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2002 Aug; 6(3):799-824. PubMed ID: 12362582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.
    Wolf DC; Bojito L; Facciuto M; Lebovics E
    Dig Dis Sci; 2009 Nov; 54(11):2519-22. PubMed ID: 19082888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.
    Aqel BA; Machicao V; Rosser B; Satyanarayana R; Harnois DM; Dickson RC
    J Clin Gastroenterol; 2004 Oct; 38(9):805-9. PubMed ID: 15365410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide for the treatment of autoimmune hepatitis.
    Snider KR; Potter TG
    Ann Pharmacother; 2011 Sep; 45(9):1144-50. PubMed ID: 21878659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of autoimmune hepatitis].
    Múzes G
    Orv Hetil; 2003 Jul; 144(30):1497-8. PubMed ID: 14569681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.